Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne's Thread in Early Cervical Cancer Treatment?
Serouart B, Cordoba A, Martinez-Gomez C, Bogart E, Le Deley MC, Leblanc É, Hudry D, Escande A, Le Tinier F, Pasquesoone C, Taieb S, El Hajj H, Narducci F. Serouart B, et al. Among authors: bogart e. Cancers (Basel). 2023 Mar 2;15(5):1570. doi: 10.3390/cancers15051570. Cancers (Basel). 2023. PMID: 36900360 Free PMC article.
Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients.
Kakkos A, Bresson L, Hudry D, Cousin S, Lervat C, Bogart E, Meurant JP, El Bedoui S, Decanter G, Hannebicque K, Regis C, Hamdani A, Penel N, Tresch-Bruneel E, Narducci F. Kakkos A, et al. Among authors: bogart e. Eur J Surg Oncol. 2017 Apr;43(4):689-695. doi: 10.1016/j.ejso.2016.10.020. Epub 2016 Nov 5. Eur J Surg Oncol. 2017. PMID: 27889197
REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis.
Berry V, Basson L, Bogart E, Mir O, Blay JY, Italiano A, Bertucci F, Chevreau C, Clisant-Delaine S, Liegl-Antzager B, Tresch-Bruneel E, Wallet J, Taieb S, Decoupigny E, Le Cesne A, Brodowicz T, Penel N. Berry V, et al. Among authors: bogart e. Cancer. 2017 Jun 15;123(12):2294-2302. doi: 10.1002/cncr.30661. Epub 2017 Mar 10. Cancer. 2017. PMID: 28295221 Free PMC article. Clinical Trial.
Outcomes of pre-operative brachytherapy followed by hysterectomy for early cervical cancer.
Bataille B, Escande A, Le Tinier F, Parent A, Bogart E, Collinet P, Bresson L, Narducci F, Leblanc E, Lemaire AS, Taieb S, Lartigau E, Mirabel X, Cordoba A. Bataille B, et al. Among authors: bogart e. Int J Gynecol Cancer. 2020 Feb;30(2):181-186. doi: 10.1136/ijgc-2019-000617. Epub 2019 Dec 22. Int J Gynecol Cancer. 2020. PMID: 31871113
Severe perioperative morbidity after robot-assisted versus conventional laparoscopy in gynecologic oncology: Results of the randomized ROBOGYN-1004 trial.
Narducci F, Bogart E, Hebert T, Gauthier T, Collinet P, Classe JM, Lecuru F, Delest A, Motton S, Conri V, Ferrer C, Marchal F, Ferron G, Probst A, Thery J, Le Deley MC, Lefebvre D, Francon D, Leblanc E, Lambaudie E. Narducci F, et al. Among authors: bogart e. Gynecol Oncol. 2020 Aug;158(2):382-389. doi: 10.1016/j.ygyno.2020.05.010. Epub 2020 May 25. Gynecol Oncol. 2020. PMID: 32467054 Clinical Trial.
Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgery.
El Hajj H, Vanseymortier M, Hudry D, Bogart E, Abdeddaim C, Leblanc E, Le Deley MC, Narducci F. El Hajj H, et al. Among authors: bogart e. ESMO Open. 2021 Apr;6(2):100098. doi: 10.1016/j.esmoop.2021.100098. Epub 2021 Apr 2. ESMO Open. 2021. PMID: 33819750 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 36402895
The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial.
Lambaudie E, Bogart E, Le Deley MC, El Hajj H, Gauthier T, Hebert T, Collinet P, Classe JM, Lecuru F, Motton S, Conri V, Ferrer C, Marchal F, Ferron G, Probst A, Jauffret C, Narducci F. Lambaudie E, et al. Among authors: bogart e. Ann Surg Oncol. 2024 Jul;31(7):4566-4575. doi: 10.1245/s10434-024-15265-1. Epub 2024 Apr 15. Ann Surg Oncol. 2024. PMID: 38616209 Free PMC article. Clinical Trial.
55 results